Xchange Prevention Registry
Xchange is an online registry dedicated to evidence-based prevention programmes, offering a wide array of thoroughly evaluated interventions. It serves as a valuable resource for implementers seeking effective...
Xchange is an online registry dedicated to evidence-based prevention programmes, offering a wide array of thoroughly evaluated interventions. It serves as a valuable resource for implementers seeking effective...
This publication answers some of the more frequently asked questions raised in discussions about cannabis legislation. While the primary focus is on the use of cannabis for recreational purposes, relevant legislation for...
Cocaine is the hydrochloride salt produced from the leaves of the coca plant. Powder cocaine is typically snorted and less frequently injected. Crack is a smokable form of cocaine and is manufactured from cocaine hydrochloride.
...The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available.
The European situation presented in Section 1 can...
Patterns of drug use and developments in the drug market in Europe are becoming more complex and dynamic, with major implications for drug monitoring and research. This observation prompted the European Monitoring Centre for...
Drug prevention approaches range from those that target society as a whole (environmental and universal prevention) to interventions focusing on at-risk individuals (indicated prevention).
The main challenges are in matching these...
Overview
Mental health problems are very common in those with a substance use disorder, and these patients have more clinically and psychosocially severe problems than patients with substance use disorders without comorbid mental health...
Between March and May 2021, the EU4Monitoring Drugs (EU4MD) project supported the mapping of national prevention systems in European Neighbourhood Policy (ENP) area countries.
This briefing describes the rationale and methodology of the...
Нова психоактивна речовина (НПС) визначається як «новий наркотичний або психотропний препарат, в чистому вигляді або в стадії підготовки, який не контролюється конвенціями Організації Об'єднаних Націй про наркотики, але який може...
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data...
Зосередження лікування на конкретних умовах, де можуть розвинутися проблеми, є важливим підходом до реалізації медичних та соціальних реакцій на проблеми з наркотиками. В результаті, EMCDDA «Здоров'я та соціальні рішення проблем з...
Зведення:
У цій статті досліджується доказова база для послуг, призначених для задоволення потреб людей, які відчувають бездомність і вживають наркотики. Завдяки розділеному аналізу існуючих систематичних та швидких оглядів доказів, він...
Європейське веб-опитування з наркотиків зібрало дані в період з березня по квітень 2021 року від людей, які вживають наркотики у віці 18 років і старше, які проживають в 21 ЄС і 9 країнах, що не є членами ЄС. У цей період населення в...
This miniguide is one of a larger set, which together comprises Health and social responses to drug problems: a European guide 2021.
It provides an overview of the most important aspects to consider when planning or delivering health and...
EMCDDA's best practice portal is designed to help you find practical and reliable information on what works (and what doesn’t) in the areas of prevention, treatment, harm reduction and social reintegration.
It will help you identify...
EMCDDA has published Policy and practice briefings in Workplaces. This policy and practice briefing provides an overview of the key issues, response options, evidence and implications for policy and practice.
It summarises the available...
The Health and social responses to drug problems: a European guide 2021 was developed to support practitioners and policymakers in tackling the negative consequences of drug use.
The guide is composed of four sets of miniguides that look...
This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the the EU Early Warning System.
The aim of this report is to strengthen situational awareness of synthetic...
People who inject drugs (PWID) are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains...
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member